Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Breaking News: Pacifica meldet neue hochgradige Entdeckung und genau deshalb kann der Markt das nicht ignorieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
258 Leser
Artikel bewerten:
(1)

Florida-Based Pharmaceutical Leader Prescription Hope Continues to Provide Quality Care Through Patient Assistance Programs

STUART, FL / ACCESSWIRE / December 17, 2020 / Nationwide pharmaceutical leader, Prescription Hope, continues to provide affordable medication solutions to patients across the country. By streamlining the medication procurement process, the company utilizes U.S. based patient assistant programs to help individuals obtain the medication they require.

"The United States healthcare system remains one of the best in the world; however, the rising cost of prescription drugs has left thousands of individuals unable to access their medication" states president, founder, and CEO Douglas Pierce.

Recent surveys show that approximately 66 percent of Americans have reported that their prescription drug prices have risen since 2017. Additionally, the global spending on prescription drugs is estimated to hit 1.3 trillion by the end of 2020, with 350 billion spent in the U.S. alone. While the rising cost of medication is the result of various factors, consumers continue to face inflated out-of-pocket expenses and are directly impacted by high price points. Several reports have highlighted individuals who have had to stop taking medications due to cost-related issues, and as a result, their health has suffered.

In an effort to help patients receive the medication they need, Prescription Hope will enroll customers in a patient assistance program, so they have access to brand name medication for the low cost of $50 per month per medication. Each pharmaceutical manufacturer will have its own forms and specific requirements; however, Prescription Hope acts as a guide to streamline the entire application process.

According to Pierce, "we at Prescription Hope take our patient's well-being seriously and work hard to ensure that all individuals who qualify for the Patient Assistant Program have access to the medication they require, at an affordable price. With more and more programs becoming available, we provide relevant information on changing guidelines, so our patients remain up-to-date on the qualification process."

Despite the challenges this year has presented, the professionals at Prescription Hope are currently maintaining full operational capacity and have implemented various social distancing measures to ensure the health and safety of our patients and staff. As a team of dedicated health care professionals, they are committed to providing unparalleled, top-quality care.

About Prescription Hope
Founded in 2006 by Douglas Pierce, Prescription Hope is a national prescription drug access program headquartered in Stuart, Florida. As one of the largest patient assistance program administrators in the U.S., the professionals at Prescription Hope have helped over 80,000 Americans receive access to affordable medication. Having partnered with over 35,000 healthcare providers nationwide, the company has worked with state and local healthcare organizations including the Cleveland Clinic, Henry Ford Health Systems, and Novant Health Systems.

Contact
Bryan Hildreth, COO
info@prescriptionhope.com
1-877-296-HOPE (4673)
Monday-Friday, 8 AM - 4 PM EST

SOURCE: Prescription Hope



View source version on accesswire.com:
https://www.accesswire.com/621454/Florida-Based-Pharmaceutical-Leader-Prescription-Hope-Continues-to-Provide-Quality-Care-Through-Patient-Assistance-Programs

© 2020 ACCESS Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.